查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1715697

生物影像市場（按技術、產品、模式、應用和最終用戶分類）—2025-2030 年全球預測

Bio-imaging Market by Technology, Product, Modality, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2024年生物成像市場價值將達67億美元，2025年將達73.8億美元，複合年成長率為10.23%，到2030年將達到120.3億美元。

主要市場統計數據
基準年2024年 67億美元
預計2025年 73.8億美元
預測年份 2030 120.3億美元
複合年成長率（%） 10.23%

生物影像是醫學創新的核心，它提供了強大的工具，改變了臨床醫生和研究人員觀察內部生命結構的方式。在當今快速發展的科學環境中，影像技術對於診斷、治療計劃和突破性研究至關重要。感測器技術、數據處理和影像處理軟體的最新進展使得疾病檢測和監測更加準確，代表了臨床和研究領域的重大突破。

工程能力與生物學洞察力的結合為創新成像解決方案鋪平了道路，這些解決方案不僅提高了診斷的準確性，還降低了侵入性。隨著成像系統變得越來越複雜，最終使用者能夠更有自信、準確地做出決策。本介紹深入探討了決定生物成像領域發展軌跡的變革、細分因素、區域動態和競爭格局。

在探索這些方面，很明顯該領域並不是孤立地發展，而是正在迅速整合跨學科創新以解決醫療保健領域長期存在的挑戰。在數據驅動和創新的推動下，生物成像透過將傳統診斷方法與現代技術突破相結合，不斷擴大其影響力，最終重塑我們對待患者照護和生物醫學研究的方式。

重塑生物影像領域的變革

隨著技術突破與新的臨床要求的融合，生物成像領域正在發生巨大的變化。這種轉變的特點是融合了多種創新，擴大了能力，提高了精確度，並降低了操作複雜性。人工智慧、先進計算技術和自動化在診斷成像領域的快速融合，不僅加快了影像擷取和分析的速度，而且提高了各種應用所需的解釋準確性。

最顯著的變化之一是混合成像系統的出現，該系統融合了不同的顯像模式，提供對生物過程的全面觀察。在強大的數據分析的支持下，這些系統為臨床醫生提供了檢測細微異常的無與倫比的準確性。硬體小型化和感測器靈敏度提高的最新進展使得人們能夠獲得更清晰、更詳細的影像，極大地促進了疾病的早期發現和精準的治療性介入。

此外，影像處理軟體的進步重新定義了醫生如何管理大型資料集和提取可操作的見解。現在，複雜的演算法和增強的影像分析工具可以對異常進行詳細量化，並追蹤疾病隨時間的進展。隨著這些變革性轉變不斷重新定義產業動態，相關人員被鼓勵接受創新，以在快速發展的市場中保持競爭力。

生物成像的全面分割洞察

生物成像市場複雜且細分，反映了推動這一動態領域的技術、產品、模式、應用和最終用戶的多樣性。從技術方面考慮，調查通常涉及多種成像模式。市場研究涉及內視鏡、磁振造影、核子醫學攝影、手術顯微鏡、超音波和X光成像等先進領域。這種技術細分提供了對每種方式如何促進診斷準確性的細緻理解，並可以指南有針對性的創新。

同時，產品細分已擴展到成像系統、儀器、試劑和軟體等不同類別。在設備類別中，特別關注 CT 掃描儀、 核磁共振造影系統和超音波診斷設備，強調這些技術在現代醫學診斷中發揮的重要作用。同樣，軟體部門分為資料管理系統和影像分析工具，兩者都有助於處理和解釋複雜的影像資料。

此外，基於模態的分割區分了 2D 和 3D 成像，為實現更具身臨其境型的診斷和治療技術提供了啟示。應用領域涵蓋臨床診斷、藥物發現、研究和治療等廣泛領域，突顯了生物影像在臨床和實驗環境中的多方面應用。最後，報告重點關注最終用戶，從門診手術中心到診斷影像中心，以及醫院和診所。每個細分市場都提供了生物成像市場的詳細全景，並為相關人員提供了發展趨勢、投資前景和技術創新機會的見解。

目錄

第1章 引言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章 市場洞察

  • 市場動態
    • 驅動程式
      • 慢性疾病和神經系統疾病盛行率不斷上升
      • 全球轉向非侵入性診斷
      • 醫療成本和醫療基礎設施投資不斷增加
    • 限制因素
      • 生物成像設備和系統的嚴格監管標準和互通性問題
    • 機會
      • 開發適用於照護現場的可攜式、價格實惠的生物成像設備
      • 擴大神經病學和腫瘤學中的生物成像應用
    • 任務
      • 與使用生物成像數據有關的倫理和隱私問題
  • 市場區隔分析
    • 技術：超音波因其價格實惠和非電離特性而越來越受到青睞
    • 最終用戶：診斷成像中心擴大生物成像的使用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社會
    • 技術的
    • 合法的
    • 環境

第6章 生物影像市場（按技術）

  • 內視鏡檢查
  • 磁振造影
  • 核子造影
  • 手術顯微鏡
  • 超音波
  • X光影像

第7章生物影像市場（按產品）

  • 影像系統
  • 裝置
    • CT掃描儀
    • 核磁共振造影系統
    • 超音波設備
  • 試劑
  • 軟體
    • 資料管理軟體
    • 影像分析軟體

第 8 章 生物造影市場（按模式）

  • 2D成像
  • 3D成像

第9章生物成像市場（按應用）

  • 臨床診斷
  • 藥物研發
  • 調查
  • 治療

第 10 章 生物影像市場（依最終使用者）

  • 門診手術中心
  • 診斷影像中心
  • 醫院和診所

第 11 章：美洲生物成像市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

12.亞太地區生物成像市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第 13 章歐洲、中東和非洲生物成像市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2024年市場佔有率分析
  • 2024年FPNV定位矩陣
  • 競爭情境分析
  • 戰略分析與建議

公司名單

  • BaySpec, Inc.
  • Bracco SpA
  • Bruker Corporation
  • Canon Medical Systems Corporation
  • Digirad Corporation
  • Esaote SpA
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies, Inc.
  • Hitachi Medical Corporation
  • HT BioImaging Ltd
  • iThera Medical GmbH
  • Kitware, Inc.
  • Koninklijke Philips NV
  • Lantheus Medical Imaging, Inc.
  • M Squared Lasers Ltd.
  • MARS Bioimaging Limited
  • Medtronic PLC
  • MobileODT Ltd by Liger Medical LLC
  • Perspectum Ltd.
  • Quibim, SL
  • RadNet, Inc.
  • Rivanna Medical, Inc.
  • Samsung Medison Co., Ltd.
  • Siemens Healthineers
Product Code: MRR-710B1F0AC3D1

The Bio-imaging Market was valued at USD 6.70 billion in 2024 and is projected to grow to USD 7.38 billion in 2025, with a CAGR of 10.23%, reaching USD 12.03 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 6.70 billion
Estimated Year [2025] USD 7.38 billion
Forecast Year [2030] USD 12.03 billion
CAGR (%) 10.23%

Bio-imaging is at the nexus of medical innovation, providing powerful tools that have transformed the way clinicians and researchers visualize internal biological structures. In today's fast-evolving scientific environment, imaging technologies are integral to diagnosis, treatment planning, and breakthrough research. Recent advances in sensor technology, data processing, and imaging software have elevated the precision of disease detection and monitoring, marking a significant leap forward in both clinical and research settings.

The convergence of engineering prowess with biological insights has paved the way for innovative imaging solutions that not only improve diagnostic accuracy but also reduce invasiveness. As imaging systems become more sophisticated, they empower end-users to make decisions with greater confidence and accuracy. This initial introduction sets the stage for a deep dive into the transformative shifts, segmentation factors, regional dynamics, and competitive landscape that are defining the trajectory of the bio-imaging arena.

As we explore these facets, it becomes evident that the sector is not merely evolving in isolation; it is rapidly integrating cross-disciplinary innovations to address longstanding challenges in healthcare. Grounded in data and driven by innovation, bio-imaging continues to expand its influence by merging traditional diagnostic practices with modern technological breakthroughs, ultimately reshaping the way we approach patient care and biomedical research.

Transformative Shifts Reshaping the Bio-Imaging Sector

The landscape of bio-imaging is undergoing dramatic transformation as technological breakthroughs converge with new clinical requirements. This transformation is characterized by an amalgamation of innovations that expand capabilities, refine accuracy, and reduce operational complexity. The rapid integration of artificial intelligence, advanced computing techniques, and automation in imaging has not only accelerated the pace at which images are acquired and analyzed but has also enhanced the interpretative accuracy required for a wide variety of applications.

One of the most notable shifts is the emergence of hybrid imaging systems that merge different imaging modalities to provide comprehensive views of biological processes. These systems, supported by robust data analytics, offer clinicians unparalleled precision in detecting subtle anomalies. Recent improvements in hardware miniaturization and sensor sensitivity allow for clearer, more detailed images that contribute significantly to early disease detection and nuanced therapeutic interventions.

Furthermore, the evolution within imaging software has redefined how practitioners manage large datasets and extract actionable insights. Refined algorithms and enhanced image analysis tools enable the detailed quantification of abnormalities and the tracking of disease progression over time. As these transformative shifts continue to redefine industry dynamics, stakeholders are encouraged to embrace innovation to maintain their competitive edge in a rapidly evolving market.

Comprehensive Segmentation Insights in Bio-Imaging

The bio-imaging market is intricately segmented, reflecting the diversity of technologies, products, modalities, applications, and end users that drive this dynamic field. When considering technological aspects, research regularly spans across multiple imaging methods. The market is studied across advanced areas such as endoscopy, magnetic resonance imaging, nuclear imaging, surgical microscopy, ultrasound, and x-ray imaging. This technological segmentation provides a nuanced understanding of how each modality contributes to diagnostic precision and guides targeted innovation.

In parallel, the product segmentation extends into distinct categories such as imaging systems, instruments, reagents, and software. Within the instruments category, particular attention is given to CT scanners, MRI machines, and ultrasound devices, all of which underscore the pivotal role these technologies play in modern medical diagnostics. Similarly, the software segment is bifurcated into data management systems and image analysis tools, both of which are instrumental in processing and interpreting complex imaging data.

Furthermore, segmentation based on modality distinguishes between 2D imaging and 3D imaging, shedding light on the transition towards more immersive diagnostic and therapeutic techniques. Within the application domain, the market examines a wide spectrum that includes clinical diagnostics, drug discovery, research, and therapeutics, highlighting the multifaceted applications of bio-imaging in both clinical and experimental settings. Lastly, a keen focus is placed on the end users, which range from ambulatory surgical centers to diagnostic imaging centers, and extend into hospitals and clinics. Each segmentation component contributes collectively to a detailed panorama of the bio-imaging market, offering insights into evolution trends, investment prospects, and innovation opportunities for stakeholders.

Based on Technology, market is studied across Endoscopy, Magnetic Resonance Imaging, Nuclear Imaging, Surgical Microscopy, Ultrasound, and X-ray Imaging.

Based on Product, market is studied across Imaging Systems, Instruments, Reagents, and Software. The Instruments is further studied across CT Scanners, MRI Machines, and Ultrasound Devices. The Software is further studied across Data Management Software and Image Analysis Software.

Based on Modality, market is studied across 2D Imaging and 3D Imaging.

Based on Application, market is studied across Clinical Diagnostics, Drug Discovery, Research, and Therapeutics.

Based on End User, market is studied across Ambulatory Surgical Centers, Diagnostic Imaging Centers, and Hospitals & Clinics.

Strategic Regional Insights in Global Bio-Imaging Markets

The evolution of bio-imaging is not just a product of technological advance; it is also shaped by regional dynamics that influence investment, market penetration, and regulatory frameworks. A thorough exploration of the market reveals distinctive trends across major regions. In the Americas, robust healthcare infrastructure coupled with aggressive adoption of advanced technologies fosters an environment ripe for innovation. This region benefits from substantial research investments and a strong network of academic institutions that often pioneer breakthroughs in imaging technology.

Transitioning to regions that encompass Europe, the Middle East, and Africa, the focus is on a blend of longstanding medical expertise and emerging markets. These regions offer a strategic balance where established healthcare systems merge with the need for innovation-driven growth. Regulatory frameworks in these regions are evolving, thus creating pathways for novel imaging modalities to integrate seamlessly with traditional practices while ensuring compliance and patient safety.

In the Asia-Pacific region, rapid urbanization, increased healthcare spending, and expanding medical infrastructure position it as a lucrative market for bio-imaging innovations. The region is experiencing swift technological adoption and a reimagining of traditional diagnostic practices, which leads to enhanced service delivery and competitive advancements. The interplay of these regional insights not only informs localized strategies but also provides a broader understanding of the global momentum driving the bio-imaging industry.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Competitive Landscape: Key Companies Driving Innovation

A competitive analysis of the bio-imaging market reveals a landscape populated by a diverse set of players, each contributing to technological breakthroughs and market expansion. Prominent companies including BaySpec, Inc. and Bracco S.p.A. demonstrate a commitment to quality and innovation that has helped set industry benchmarks. These firms, together with Bruker Corporation and Canon Medical Systems Corporation, are instrumental in pushing the envelope of imaging technologies, ensuring that state-of-the-art systems meet current clinical needs.

Further reinforcing industry dynamism are organizations such as Digirad Corporation, Esaote S.p.A., and Fujifilm Holdings Corporation, which have carved niches in niche areas ranging from advanced imaging systems to specialized reagents. GE HealthCare Technologies, Inc. and Hitachi Medical Corporation continue to be pioneering figures in elevating imaging capabilities with their extensive research and development initiatives. HT BioImaging Ltd and iThera Medical GmbH also showcase their prowess in combining research-grade technologies with practical applications to enhance diagnostic accuracy.

Additional market influencers such as Kitware, Inc., Koninklijke Philips N.V., and Lantheus Medical Imaging, Inc. remain at the forefront of software-driven imaging innovations, complemented by M Squared Lasers Ltd. and MARS Bioimaging Limited, who contribute through precision hardware innovations. Medtronic PLC and MobileODT Ltd by Liger Medical LLC further exemplify the entrepreneurial spirit in this sector, leveraging cutting-edge technology to redefine patient imaging protocols. Industry specialists including Perspectum Ltd., Quibim, S.L., RadNet, Inc., and Rivanna Medical, Inc. maintain high standards in imaging performance, while Samsung Medison Co., Ltd. and Siemens Healthineers are recognized globally for their comprehensive healthcare solutions. Together, these companies form a robust network of innovators whose contributions are indispensable in driving the bio-imaging field toward a future of enhanced diagnostic and therapeutic performance.

The report delves into recent significant developments in the Bio-imaging Market, highlighting leading vendors and their innovative profiles. These include BaySpec, Inc., Bracco S.p.A., Bruker Corporation, Canon Medical Systems Corporation, Digirad Corporation, Esaote S.p.A, Fujifilm Holdings Corporation, GE HealthCare Technologies, Inc., Hitachi Medical Corporation, HT BioImaging Ltd, iThera Medical GmbH, Kitware, Inc., Koninklijke Philips N.V., Lantheus Medical Imaging, Inc., M Squared Lasers Ltd., MARS Bioimaging Limited, Medtronic PLC, MobileODT Ltd by Liger Medical LLC, Perspectum Ltd., Quibim, S.L., RadNet, Inc., Rivanna Medical, Inc., Samsung Medison Co., Ltd., and Siemens Healthineers. Strategic Recommendations for Navigating the Bio-Imaging Market

Industry leaders are encouraged to adopt a multipronged strategy that emphasizes continued investment in research and development, collaboration across disciplines, and an agile response to regulatory changes. It is imperative that decision-makers harness the potential of advanced analytics and artificial intelligence to process the ever-growing volume of imaging data. By integrating data-driven insights into strategic planning, companies can preemptively address market shifts and tailor their product portfolios to meet evolving clinical needs.

To remain competitive, companies should prioritize partnerships that bridge the gap between engineering innovations and biological applications. Engaging in joint ventures or collaborations with academic institutions and research organizations can facilitate access to cutting-edge technologies and foster a culture of continuous improvement. Furthermore, adopting a global perspective that accounts for regional variances in healthcare infrastructure and regulatory environments will enhance a company's ability to customize solutions to local market demands.

Leaders would also benefit from streamlining operational workflows and investing in digital transformation initiatives that drive efficiency. This includes enhancing cybersecurity protocols and ensuring robust data governance to protect sensitive patient information. Ultimately, a forward-thinking approach that balances innovation with operational excellence will be key to harnessing the full potential of the bio-imaging market.

Conclusion: The Future Landscape of Bio-Imaging

In summary, the trajectory of bio-imaging is steering toward a future that is marked by technological integration, strategic segmentation, and robust regional dynamics. The insights gleaned from advanced imaging systems, segmented analyses across technology, product, modality, application, and end user, display a market that is thriving on innovation and collaboration. Through transformative shifts in both hardware and software capabilities, bio-imaging is not only enhancing clinical outcomes but also paving the way for novel research frontiers.

The ongoing evolution in imaging technology and data analytics promises to unlock new possibilities in precision medicine, thereby shaping the future of healthcare delivery on a global scale. As healthcare providers and innovators continue to navigate a landscape defined by rapid change, the need for astute market analysis and proactive strategic planning becomes increasingly apparent. This conclusion underscores the relevance of staying informed about the latest trends and being prepared to take decisive action in a competitive environment.

Ultimately, by embracing a holistic view that merges innovation with practical application, stakeholders can drive meaningful improvements in patient care and clinical research, ensuring that bio-imaging remains at the forefront of medical advancement.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of chronic diseases and neurological disorders
      • 5.1.1.2. Global shift toward non-invasive diagnostic methods
      • 5.1.1.3. Rising healthcare expenditure and investments in healthcare infrastructure
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent regulatory standards and interoperability issues of bio-imaging devices and systems
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of portable and affordable bio-imaging devices for use in point-of-care settings
      • 5.1.3.2. Expansion of bio-imaging applications within the neurology and oncology sectors
    • 5.1.4. Challenges
      • 5.1.4.1. Ethical and privacy concerns associated with use of bio-imaging data
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Technology: Increasing preference for ultrasound due to its affordability and non-ionizing nature
    • 5.2.2. End User: Expanding usage of bio-imaging by diagnostic imaging centers
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Bio-imaging Market, by Technology

  • 6.1. Introduction
  • 6.2. Endoscopy
  • 6.3. Magnetic Resonance Imaging
  • 6.4. Nuclear Imaging
  • 6.5. Surgical Microscopy
  • 6.6. Ultrasound
  • 6.7. X-ray Imaging

7. Bio-imaging Market, by Product

  • 7.1. Introduction
  • 7.2. Imaging Systems
  • 7.3. Instruments
    • 7.3.1. CT Scanners
    • 7.3.2. MRI Machines
    • 7.3.3. Ultrasound Devices
  • 7.4. Reagents
  • 7.5. Software
    • 7.5.1. Data Management Software
    • 7.5.2. Image Analysis Software

8. Bio-imaging Market, by Modality

  • 8.1. Introduction
  • 8.2. 2D Imaging
  • 8.3. 3D Imaging

9. Bio-imaging Market, by Application

  • 9.1. Introduction
  • 9.2. Clinical Diagnostics
  • 9.3. Drug Discovery
  • 9.4. Research
  • 9.5. Therapeutics

10. Bio-imaging Market, by End User

  • 10.1. Introduction
  • 10.2. Ambulatory Surgical Centers
  • 10.3. Diagnostic Imaging Centers
  • 10.4. Hospitals & Clinics

11. Americas Bio-imaging Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Bio-imaging Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Bio-imaging Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. UCSF and GE HealthCare collaborate to advance bio-imaging innovations in brain health and oncology
    • 14.3.2. Nikon strengthens European bio-imaging capabilities with expansion of BioImaging Labs to boost drug discovery efforts
    • 14.3.3. Strategic partnership between MARS Bioimaging and Linkoping University sets new standards in photon-counting CT technology advancement
    • 14.3.4. UK and India Unite to Tackle Big Data Challenges for Groundbreaking Telescope Project
    • 14.3.5. HSS and MARS Bioimaging Collaborate to Revolutionize Musculoskeletal Imaging with Advanced Photon-Counting CT Technology from CERN
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. BaySpec, Inc.
  • 2. Bracco S.p.A.
  • 3. Bruker Corporation
  • 4. Canon Medical Systems Corporation
  • 5. Digirad Corporation
  • 6. Esaote S.p.A
  • 7. Fujifilm Holdings Corporation
  • 8. GE HealthCare Technologies, Inc.
  • 9. Hitachi Medical Corporation
  • 10. HT BioImaging Ltd
  • 11. iThera Medical GmbH
  • 12. Kitware, Inc.
  • 13. Koninklijke Philips N.V.
  • 14. Lantheus Medical Imaging, Inc.
  • 15. M Squared Lasers Ltd.
  • 16. MARS Bioimaging Limited
  • 17. Medtronic PLC
  • 18. MobileODT Ltd by Liger Medical LLC
  • 19. Perspectum Ltd.
  • 20. Quibim, S.L.
  • 21. RadNet, Inc.
  • 22. Rivanna Medical, Inc.
  • 23. Samsung Medison Co., Ltd.
  • 24. Siemens Healthineers

LIST OF FIGURES

  • FIGURE 1. BIO-IMAGING MARKET MULTI-CURRENCY
  • FIGURE 2. BIO-IMAGING MARKET MULTI-LANGUAGE
  • FIGURE 3. BIO-IMAGING MARKET RESEARCH PROCESS
  • FIGURE 4. BIO-IMAGING MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL BIO-IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIO-IMAGING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL BIO-IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BIO-IMAGING MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL BIO-IMAGING MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BIO-IMAGING MARKET SIZE, BY MODALITY, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL BIO-IMAGING MARKET SIZE, BY MODALITY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL BIO-IMAGING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL BIO-IMAGING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL BIO-IMAGING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL BIO-IMAGING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS BIO-IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 19. AMERICAS BIO-IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES BIO-IMAGING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 21. UNITED STATES BIO-IMAGING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. BIO-IMAGING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 27. BIO-IMAGING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BIO-IMAGING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BIO-IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIO-IMAGING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIO-IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIO-IMAGING MARKET DYNAMICS
  • TABLE 7. GLOBAL BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIO-IMAGING MARKET SIZE, BY ENDOSCOPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIO-IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIO-IMAGING MARKET SIZE, BY NUCLEAR IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIO-IMAGING MARKET SIZE, BY SURGICAL MICROSCOPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIO-IMAGING MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIO-IMAGING MARKET SIZE, BY X-RAY IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIO-IMAGING MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIO-IMAGING MARKET SIZE, BY CT SCANNERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BIO-IMAGING MARKET SIZE, BY MRI MACHINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIO-IMAGING MARKET SIZE, BY ULTRASOUND DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIO-IMAGING MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BIO-IMAGING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BIO-IMAGING MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BIO-IMAGING MARKET SIZE, BY IMAGE ANALYSIS SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL BIO-IMAGING MARKET SIZE, BY 2D IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL BIO-IMAGING MARKET SIZE, BY 3D IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL BIO-IMAGING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL BIO-IMAGING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL BIO-IMAGING MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL BIO-IMAGING MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL BIO-IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL BIO-IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL BIO-IMAGING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS BIO-IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 71. MEXICO BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 79. UNITED STATES BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES BIO-IMAGING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 94. AUSTRALIA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 95. AUSTRALIA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. AUSTRALIA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. CHINA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. CHINA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 100. CHINA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 101. CHINA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 102. CHINA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. CHINA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 105. INDIA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. INDIA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 107. INDIA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 108. INDIA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 109. INDIA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. INDIA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 112. INDONESIA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. INDONESIA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 114. INDONESIA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 115. INDONESIA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 116. INDONESIA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. INDONESIA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. JAPAN BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. JAPAN BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 121. JAPAN BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 122. JAPAN BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 123. JAPAN BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. JAPAN BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 126. MALAYSIA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. MALAYSIA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 128. MALAYSIA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 129. MALAYSIA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 130. MALAYSIA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. MALAYSIA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. PHILIPPINES BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. PHILIPPINES BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 135. PHILIPPINES BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 136. PHILIPPINES BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 137. PHILIPPINES BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. PHILIPPINES BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 140. SINGAPORE BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. SINGAPORE BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 142. SINGAPORE BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 143. SINGAPORE BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 144. SINGAPORE BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. SINGAPORE BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 147. SOUTH KOREA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. SOUTH KOREA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 149. SOUTH KOREA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 150. SOUTH KOREA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 151. SOUTH KOREA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. SOUTH KOREA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 154. TAIWAN BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. TAIWAN BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 156. TAIWAN BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 157. TAIWAN BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 158. TAIWAN BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. TAIWAN BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 161. THAILAND BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. THAILAND BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 163. THAILAND BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 164. THAILAND BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 165. THAILAND BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. THAILAND BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 168. VIETNAM BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. VIETNAM BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 170. VIETNAM BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 171. VIETNAM BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 172. VIETNAM BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. VIETNAM BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. DENMARK BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. DENMARK BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 185. DENMARK BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 186. DENMARK BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 187. DENMARK BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. DENMARK BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 190. EGYPT BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. EGYPT BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 192. EGYPT BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 193. EGYPT BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 194. EGYPT BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. EGYPT BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 197. FINLAND BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. FINLAND BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 199. FINLAND BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 200. FINLAND BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 201. FINLAND BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. FINLAND BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 204. FRANCE BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 205. FRANCE BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 206. FRANCE BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 207. FRANCE BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 208. FRANCE BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 209. FRANCE BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 211. GERMANY BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 212. GERMANY BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 213. GERMANY BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 214. GERMANY BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 215. GERMANY BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 216. GERMANY BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 218. ISRAEL BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 219. ISRAEL BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 220. ISRAEL BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 221. ISRAEL BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 222. ISRAEL BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. ISRAEL BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 225. ITALY BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 226. ITALY BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 227. ITALY BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 228. ITALY BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 229. ITALY BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 230. ITALY BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 232. NETHERLANDS BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 233. NETHERLANDS BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 234. NETHERLANDS BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 235. NETHERLANDS BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 236. NETHERLANDS BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 237. NETHERLANDS BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 239. NIGERIA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 240. NIGERIA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 241. NIGERIA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 242. NIGERIA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 243. NIGERIA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 244. NIGERIA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 246. NORWAY BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 247. NORWAY BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 248. NORWAY BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 249. NORWAY BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 250. NORWAY BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 251. NORWAY BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 253. POLAND BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 254. POLAND BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 255. POLAND BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 256. POLAND BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 257. POLAND BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 258. POLAND BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 260. QATAR BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 261. QATAR BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 262. QATAR BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 263. QATAR BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 264. QATAR BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 265. QATAR BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 267. RUSSIA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 268. RUSSIA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 269. RUSSIA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 270. RUSSIA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 271. RUSSIA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 272. RUSSIA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 274. SAUDI ARABIA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 275. SAUDI ARABIA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 276. SAUDI ARABIA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 277. SAUDI ARABIA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 278. SAUDI ARABIA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 279. SAUDI ARABIA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH AFRICA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 281. SOUTH AFRICA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 282. SOUTH AFRICA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 283. SOUTH AFRICA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 284. SOUTH AFRICA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 285. SOUTH AFRICA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 286. SOUTH AFRICA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 287. SPAIN BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 288. SPAIN BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 289. SPAIN BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 290. SPAIN BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 291. SPAIN BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 292. SPAIN BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 293. SPAIN BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 294. SWEDEN BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 295. SWEDEN BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 296. SWEDEN BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 297. SWEDEN BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 298. SWEDEN BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 299. SWEDEN BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 300. SWEDEN BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 301. SWITZERLAND BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 302. SWITZERLAND BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 303. SWITZERLAND BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 304. SWITZERLAND BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 305. SWITZERLAND BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 306. SWITZERLAND BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 307. SWITZERLAND BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 308. TURKEY BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 309. TURKEY BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 310. TURKEY BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 311. TURKEY BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 312. TURKEY BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 313. TURKEY BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 314. TURKEY BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 315. UNITED ARAB EMIRATES BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 316. UNITED ARAB EMIRATES BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 317. UNITED ARAB EMIRATES BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 318. UNITED ARAB EMIRATES BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 319. UNITED ARAB EMIRATES BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 320. UNITED ARAB EMIRATES BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 321. UNITED ARAB EMIRATES BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 322. UNITED KINGDOM BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 323. UNITED KINGDOM BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 324. UNITED KINGDOM BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 325. UNITED KINGDOM BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 326. UNITED KINGDOM BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 327. UNITED KINGDOM BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 328. UNITED KINGDOM BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 329. BIO-IMAGING MARKET SHARE, BY KEY PLAYER, 2024
  • TABLE 330. BIO-IMAGING MARKET, FPNV POSITIONING MATRIX, 2024